These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37295676)

  • 1. Etiology and utility of hospital-onset bacteremia as a safety metric for targeted harm reduction.
    Stack MA; Dbeibo L; Fadel W; Kelley K; Sadowski J; Beeler C
    Am J Infect Control; 2024 Feb; 52(2):195-199. PubMed ID: 37295676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and preventability of hospital-onset bacteremia and fungemia in 2 hospitals in India.
    Gandra S; Singh SK; Chakravarthy M; Moni M; Dhekane P; Mohamed Z; Shameen F; Vasudevan AK; Senthil P; Saravanan T; George A; Sinclair D; Stwalley D; van Rheenen J; Westercamp M; Smith RM; Leekha S; Warren DK
    Infect Control Hosp Epidemiol; 2024 Feb; 45(2):157-166. PubMed ID: 37593953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics, costs, and outcomes associated with central-line-associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals.
    Yu KC; Jung M; Ai C
    Infect Control Hosp Epidemiol; 2023 Dec; 44(12):1920-1926. PubMed ID: 37424226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multicenter Longitudinal Study of Hospital-Onset Bacteremia: Time for a New Quality Outcome Measure?
    Rock C; Thom KA; Harris AD; Li S; Morgan D; Milstone AM; Caffo B; Joshi M; Leekha S
    Infect Control Hosp Epidemiol; 2016 Feb; 37(2):143-8. PubMed ID: 26493213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study.
    Leekha S; Robinson GL; Jacob JT; Fridkin S; Shane A; Sick-Samuels A; Milstone AM; Nair R; Perencevich E; Puig-Asensio M; Kobayashi T; Mayer J; Lewis J; Bleasdale S; Wenzler E; Mena Lora AJ; Baghdadi J; Schrank GM; Wilber E; Aldredge AA; Sharp J; Dyer KE; Kendrick L; Ambalam V; Borgetti S; Carmack A; Gushiken A; Patel A; Reddy S; Brown CH; Dantes RB; Harris AD;
    BMJ Qual Saf; 2024 Jul; 33(8):487-498. PubMed ID: 38782579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital epidemiologists' and infection preventionists' opinions regarding hospital-onset bacteremia and fungemia as a potential healthcare-associated infection metric.
    Dantes RB; Abbo LM; Anderson D; Hall L; Han JH; Harris AD; Leekha S; Milstone AM; Morgan DJ; Safdar N; Schweizer ML; Sengupta S; Seo SK; Rock C
    Infect Control Hosp Epidemiol; 2019 May; 40(5):536-540. PubMed ID: 30932802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective surveillance of device-associated health care-associated infection in an intensive care unit of a tertiary care hospital in New Delhi, India.
    Kumar S; Sen P; Gaind R; Verma PK; Gupta P; Suri PR; Nagpal S; Rai AK
    Am J Infect Control; 2018 Feb; 46(2):202-206. PubMed ID: 29046215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of pathogens in central line-associated bloodstream infections among patients with and without neutropenia following chemotherapy: evidence for a proposed modification to the current surveillance definition.
    Steinberg JP; Robichaux C; Tejedor SC; Reyes MD; Jacob JT
    Infect Control Hosp Epidemiol; 2013 Feb; 34(2):171-5. PubMed ID: 23295563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals.
    Worth LJ; Brett J; Bull AL; McBryde ES; Russo PL; Richards MJ
    Am J Infect Control; 2009 Oct; 37(8):643-8. PubMed ID: 19589619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-Year Hospital-Wide Surveillance of Central Line-Associated Bloodstream Infections in a Korean Hospital.
    Seo HK; Hwang JH; Shin MJ; Kim SY; Song KH; Kim ES; Kim HB
    J Korean Med Sci; 2018 Nov; 33(45):e280. PubMed ID: 30402047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Device-associated nosocomial infection in general hospitals, Kingdom of Saudi Arabia, 2013-2016.
    Gaid E; Assiri A; McNabb S; Banjar W
    J Epidemiol Glob Health; 2018 Mar; 7 Suppl 1(Suppl 1):S35-S40. PubMed ID: 29801591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statewide validation of hospital-reported central line-associated bloodstream infections: Oregon, 2009.
    Oh JY; Cunningham MC; Beldavs ZG; Tujo J; Moore SW; Thomas AR; Cieslak PR
    Infect Control Hosp Epidemiol; 2012 May; 33(5):439-45. PubMed ID: 22476268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hospital-onset bloodstream infections compared to central line...associated bloodstream infections at an acute, tertiary care hospital.
    Gurney H; White J; Sweeney J; Valyko A; Washer L
    Am J Infect Control; 2023 Oct; 51(10):1120-1123. PubMed ID: 37054893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Mar; 60(8):243-8. PubMed ID: 21368740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from a hospital-wide review of blood stream infections for paediatric central line-associated blood stream infection prevention.
    Campbell AJ; Blyth CC; Hewison CJ; Chen YP; Gough L; Goff Z; Bowen AC
    J Paediatr Child Health; 2019 Jun; 55(6):690-694. PubMed ID: 30315622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Care-Associated Infections in a Neurocritical Care Unit of a Developing Country.
    Abulhasan YB; Abdullah AA; Shetty SA; Ramadan MA; Yousef W; Mokaddas EM
    Neurocrit Care; 2020 Jun; 32(3):836-846. PubMed ID: 31562598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital-acquired Staphylococcus aureus primary bloodstream infection: A comparison of events that do and do not meet the central line-associated bloodstream infection definition.
    Kovacs CS; Fatica C; Butler R; Gordon SM; Fraser TG
    Am J Infect Control; 2016 Nov; 44(11):1252-1255. PubMed ID: 27158091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of central line bundles on the timing of catheter-associated bloodstream infections and their microbiological distribution in critically ill children.
    Devrim İ; Sandal OS; Çelebi MY; Hepduman P; Gönüllü A; Atakul G; Kara AA; Oruç Y; Gülfidan G; Bayram N; Ağın H
    Eur J Pediatr; 2023 Oct; 182(10):4625-4632. PubMed ID: 37555974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections.
    Lessa FC; Mu Y; Ray SM; Dumyati G; Bulens S; Gorwitz RJ; Fosheim G; DeVries AS; Schaffner W; Nadle J; Gershman K; Fridkin SK; ;
    Clin Infect Dis; 2012 Jul; 55(2):232-41. PubMed ID: 22523264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition.
    See I; Iwamoto M; Allen-Bridson K; Horan T; Magill SS; Thompson ND
    Infect Control Hosp Epidemiol; 2013 Aug; 34(8):769-76. PubMed ID: 23838215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.